BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 24632537)

  • 1. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the detection of designer steroids in anti-doping.
    Abushareeda W; Fragkaki A; Vonaparti A; Angelis Y; Tsivou M; Saad K; Kraiem S; Lyris E; Alsayrafi M; Georgakopoulos C
    Bioanalysis; 2014 Mar; 6(6):881-96. PubMed ID: 24702116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional supplements cross-contaminated and faked with doping substances.
    Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontargeted detection of designer androgens: Underestimated role of in vitro bioassays.
    Lund RA; Cooper ER; Wang H; Ashley Z; Cawley AT; Heather AK
    Drug Test Anal; 2021 May; 13(5):894-902. PubMed ID: 33864649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis.
    Pozo OJ; De Brabanter N; Fabregat A; Segura J; Ventura R; Van Eenoo P; Deventer K
    Bioanalysis; 2013 Nov; 5(21):2661-77. PubMed ID: 24180506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling the inclusion of non-hydrolysed sulfated long term anabolic steroid metabolites in a screening for doping substances by means of gas chromatography quadrupole time-of-flight mass spectrometry.
    Albertsdóttir AD; Van Gansbeke W; Van Eenoo P; Polet M
    J Chromatogr A; 2021 Apr; 1642():462039. PubMed ID: 33735641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gas chromatography/quadrupole time-of-flight and quadrupole Orbitrap mass spectrometry in anti-doping analysis: I. Detection of anabolic-androgenic steroids.
    Abushareeda W; Tienstra M; Lommen A; Blokland M; Sterk S; Kraiem S; Horvatovich P; Nielen M; Al-Maadheed M; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2018 Dec; 32(23):2055-2064. PubMed ID: 30216576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.
    Cadwallader AB; Lim CS; Rollins DE; Botrè F
    J Anal Toxicol; 2011 Nov; 35(9):594-607. PubMed ID: 22080898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio.
    Athanasiadou I; Voss S; Lyris E; Aljaber A; Alsayrafi M; Georgakopoulos C
    Bioanalysis; 2016 Nov; 8(21):2265-2279. PubMed ID: 27665839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical strategy for detecting doping agents in hair.
    Thieme D; Grosse J; Sachs H; Mueller RK
    Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ten-year assessment of anabolic steroid misuse among competitive athletes in Puerto Rico.
    Acevedo P; Jorge JC; Cruz-Sánchez A; Amy E; Barreto-Estrada JL
    West Indian Med J; 2011 Oct; 60(5):531-5. PubMed ID: 22519228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P; Delbeke FT
    J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual banned-substance review - Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2020 Jan; 12(1):7-26. PubMed ID: 31724288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.